HLA-A2/4-1BBL-expressing allogeneic cell vaccine (Hadassah Medical Organization)
N/A
Report date: 2022/11/27 13:48:35
Base Information
Drug NameHLA-A2/4-1BBL-expressing allogeneic cell vaccine (Hadassah Medical Organization)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHadassah Medical Organization
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesHadassah Medical Organization
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A